Tipsheet
What matters at India’s listed companies
Earnings · Healthcare · Micro cap

Lotus Eye Hospital swings to loss as expansion costs mount

A push to grow the branch network has hit the bottom line, with annual profit falling to ₹8.04 lakhs and a Q4 net loss of ₹31.95 lakhs.

2 earlier stories on Lotus Eye Hospital And Institute Ltd.
Mkt cap₹228 cr
P/E348.47×
ROE1.23%
Debt / eq.0.01
₹31.95 lakhs Net loss reported for the quarter ended March 31, 2026.

What's new

  • Annual profit dropped to ₹8.04 lakhs from ₹73.93 lakhs in FY25.
  • The company added ₹1,017.40 lakhs in new non-current debt.
  • Capital expenditure for the year reached ₹1,294.91 lakhs.

Why this matters

The company is betting its future on a rapid branch expansion, but the immediate cost is a sharp erosion of profitability. Taking on over ₹10 crore in new debt to fund this growth leaves little room for error in the coming quarters.

What we're watching

  • Whether the new branches begin contributing to revenue in FY27.
  • The company's ability to service its new debt load.
  • If the current expansion phase concludes or requires further capital.

The full read

Lotus Eye Hospital is paying a high price for its growth. While annual revenue grew 8.4% to ₹53.71 crores, the company's bottom line collapsed as expansion costs surged. Net profit for the year plummeted to ₹8.04 lakhs from ₹73.93 lakhs in the previous year.

The final quarter was particularly difficult, with the company reporting a net loss of ₹31.95 lakhs.

To fund this aggressive branch network expansion, the company invested ₹1,294.91 lakhs in property, plant, and equipment. It also took on ₹1,017.40 lakhs in new non-current debt, a significant shift for a company that previously carried no such long-term borrowings. The auditors provided an unmodified opinion, but the financial strain of this expansion is clear. The company is now in a high-stakes phase where it must prove that its new branches can generate enough cash to justify the debt and restore profitability. It won't be easy.

Questions answered

How did the company's annual performance compare to the previous year?
Net profit fell to ₹8.04 lakhs in FY26, down from ₹73.93 lakhs in FY25, despite an 8.4% increase in annual revenue to ₹53.71 crores.
What is driving the decline in profitability?
The company is in an expansion phase, having invested ₹1,294.91 lakhs in property, plant, and equipment during the year.
How is the expansion being funded?
Lotus Eye Hospital has taken on ₹1,017.40 lakhs in new non-current debt, whereas it held no such debt in the prior year.
Did the auditors raise any concerns?
No, the auditors issued an unmodified opinion on the annual financial results.
Mentioned: Lotus Eye Hospital And Institute Ltd. · FY26 · FY25
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

  1. 26 May 2026 · 8:35 PM IST Lotus Eye Hospital swings to loss as expansion costs mount
  2. today Lotus Eye Hospital confirms FY26 results in routine filing
  3. today Lotus Eye Hospital swings to loss as expansion costs mount